Research Options:

Week of Expected Pricing Withdrawn
Company Name WCG CLINICAL INC
Proposed Ticker WCGC
CUSIP 92941R109
Business Description A leading provider of clinical trial solutions, focused on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance. Our transformational solutions enable biopharmaceutical companies, contract research organizations (“CROs”), and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human protection.
Lead Underwriter Barclays Capital Inc, BofA Securities, Inc, Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC
Co-Managers BMO Capital Markets Corp, HSBC Securities (USA) Inc., Jefferies LLC, SVB Leerink LLC, UBS Investment Bank, William Blair & Company, L.L.C.
Initial Shares 4,50,00,000
Revised Initial Shares N/A
Initial Price $15.00-$17.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.